TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120071628A1
SERIAL NO

13256012

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is a topical therapeutic agent for ophthalmic diseases, which comprises a compound capable of binding specifically to a DNA sequence. More preferably disclosed is a topical therapeutic agent for ophthalmic diseases, which comprise a pyrrole-imidazole polyamide having a specific structure. The topical therapeutic agent for ophthalmic diseases comprises a pyrrole-imidazole polyamide which can inhibit transforming growth factor-β gene and matrix metalloproteinase 9 gene.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
NIHON UNIVERSITYTOKYO49

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Min Tokyo, JP 129 1629
Fukuda, Noboru Tokyo, JP 9 33
Nagase, Hiroki Tokyo, JP 10 12
Sakimoto, Tohru Tokyo, JP 1 0
Watanabe, Takayoshi Tokyo, JP 16 206

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Gentier Biosystems Incorporation (1)
* 7888516 TGF-β gene expression inhibitor 0 2005
 
JAPAN SCIENCE AND TECHNOLOGY AGENCY (1)
* 2005/0176,647 Novel hairpin polyamide 0 2003
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

  • No Forward Cites to Display